26 related articles for article (PubMed ID: 3563968)
1. Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement- a hybrid model with genetic algorithm and Back-Propagation neural network.
Li Q; Tao H; Wang J; Zhou Q; Chen J; Qin WZ; Dong L; Fu B; Hou JL; Chen J; Zhang WH
Sci Rep; 2018 Jun; 8(1):9712. PubMed ID: 29946101
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.
Carlquist JF; Horne BD; Mower C; Park J; Huntinghouse J; McKinney JT; Muhlestein JB; Anderson JL
J Thromb Thrombolysis; 2010 Oct; 30(3):358-64. PubMed ID: 20499136
[TBL] [Abstract][Full Text] [Related]
3. Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing.
Carlquist JF; McKinney JT; Nicholas ZP; Clark JL; Kahn SF; Horne BD; Muhlestein JB; May HT; Anderson JL
J Thromb Thrombolysis; 2008 Aug; 26(1):1-7. PubMed ID: 17661181
[TBL] [Abstract][Full Text] [Related]
4. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.
Vadher B; Patterson DL; Leaning M
Br J Clin Pharmacol; 1999 Jul; 48(1):63-70. PubMed ID: 10383562
[TBL] [Abstract][Full Text] [Related]
6. Long-term anticoagulation. Indications and management.
Stults BM; Dere WH; Caine TH
West J Med; 1989 Oct; 151(4):414-29. PubMed ID: 2686173
[TBL] [Abstract][Full Text] [Related]
7. Racial and ethnic differences in warfarin response.
El Rouby S; Mestres CA; LaDuca FM; Zucker ML
J Heart Valve Dis; 2004 Jan; 13(1):15-21. PubMed ID: 14765833
[TBL] [Abstract][Full Text] [Related]
8. Initiating warfarin therapy: 5 mg versus 10 mg.
Eckhoff CD; Didomenico RJ; Shapiro NL
Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
Carter BL; Taylor JW; Becker A
Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
[TBL] [Abstract][Full Text] [Related]
11. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
Lee C; Coleman RW; Mungall DR
Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
[TBL] [Abstract][Full Text] [Related]
12. Changes in the pharmacology of warfarin during long-term administration in dogs.
Covell DG; Abbrecht PH; Powers WF
J Lab Clin Med; 1984 Feb; 103(2):272-83. PubMed ID: 6693797
[TBL] [Abstract][Full Text] [Related]
13. Predicting warfarin maintenance dosage based on initial response.
Miller DR; Brown MA
Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
[TBL] [Abstract][Full Text] [Related]
14. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
Weiss P; Halkin H; Almog S
Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
